GMP: Serious GMP Violations found at Chinese API Manufacturer - Basic GMP principles not followed

14.08.2014

On 7 July 2014 the US FDA has issued a Warning Letter for Zhejiang Jiuzhou Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang Province in China. The company is a producer of APIs and failed to establish basic GMP principles.